Hepatitis C News and Research

Latest Hepatitis C News and Research

Alarming number of life-threatening heart infections related to drug abuse

As the nationwide opioid epidemic continues, more young people are developing a life-threatening heart infection that can result from drug abuse.

18 Sep 2019

HCV-infected donor kidneys are safe and functional one year post-transplantation

A recent analysis reveals that kidneys from donors infected with hepatitis C virus are now routinely used in transplants at many U.S. centers, and they are functioning well one year after transplantation.

13 Sep 2019

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

A study involving military veterans with PTSD and cirrhosis of the liver points to an abnormal mix of bacteria in the intestines as a possible driver of poor cognitive performance--and as a potential target for therapy.

13 Sep 2019

Paid family leave increases immunization rates in infants

Parents who take paid family leave after the birth of a newborn are more likely to have their child vaccinated on time compared to those who do not, according to new research from Binghamton University, State University of New York. The effect is stronger on families living below the poverty line.

9 Sep 2019

Facebook takes a stand against Anti-vaxxers and vaccine misinformation

Vaccination conspiracy theories and false information regarding vaccination safety has led to decline in vaccine uptake among millions of parents for their children. This has resulted in the comeback of infections that could be prevented by widespread vaccination such as measles, whooping cough etc.

8 Sep 2019

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

Hepatitis C is a viral infection that affects the liver and is usually acquired from infected blood. Formerly called non-A, non-B hepatitis, this infection causes inflammation of the liver, sometimes causing serious liver damage.

2 Sep 2019

Study finds transplantation of Hepatitis C-infected donor kidneys to uninfected recipients to be safe

Transplantation of kidneys from Hepatitis C-infected donors to uninfected recipients is safe and can be successfully implemented as a standard of care, according to an observational study by physicians at the University of Tennessee Health Science Center and the James D. Eason Transplant Institute at Methodist University Hospital.

30 Aug 2019

NIH announces new round of funding for Research Centers in Minority Institutions

The National Institute on Minority Health and Health Disparities, part of the National Institutes of Health, has funded three new awards and renewed the awards of eight institutions previously funded under the Research Centers in Minority Institutions Specialized Centers program.

26 Aug 2019

French organ transplant centers more likely to accept kidneys discarded in the United States

French organ transplant centers are far more likely to accept "lower-rated" kidneys, like those from older organ donors, than centers in the United States, according to a first-of-its kind analysis published today in JAMA Internal Medicine.

26 Aug 2019

Needle stick injuries are common and can transmit many blood-borne pathogens

Needle stick injuries (NSIs) can transmit more than 20 blood-borne pathogens, including HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and, more rarely, malaria, human T cell leukemia virus and Ebola.

25 Aug 2019

Enzyme induced by stress associated with liver cancer growth

An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.

22 Aug 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.

10 Aug 2019

Researchers awarded $1.8 million NIH grant to study chronic liver inflammation

A team of researchers at The University of Kansas Cancer Center have been awarded a five-year, $1.8 million grant from the National Institutes of Health to study chronic inflammation of the liver, a major factor in the development of liver cancer.

9 Aug 2019

HistoIndex, ILBS launch Center of Excellence to enhance NASH diagnostics and clinical trials

In a cross border collaboration, HistoIndex and the Institute of Liver & Biliary Sciences (ILBS) in New Delhi, India have jointly launched a Centre of Excellence to aid diagnostics and clinical trials focusing on NASH.

8 Aug 2019

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.

3 Aug 2019

Trump administration ‘open for business’ on drug imports from Canada

A year after calling proposals allowing Americans to import cheaper drugs from Canada a "gimmick," Health and Human Services Secretary Alex Azar said the federal government is "open for business" on such a strategy.

31 Jul 2019

UM researchers receive $14 million from NIH for cutting-edge HIV research

The National Institutes of Health has awarded University of Miami researchers $14 million for an ambitious seven-year project that will keep the Miller School of Medicine at the forefront of cutting-edge HIV research.

30 Jul 2019

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

A new report by the World Health Organization (WHO) shows that 4.5 million deaths could be prevented by 2030, and 26 million beyond that, if 67 countries in the low- and middle-income bracket invest $6 billion a year towards abolishing hepatitis. Hepatitis is a completely preventable and treatable illness at present, and in fact, hepatitis C is completely curable.

29 Jul 2019

Researchers demonstrate positive and negative role of LRH-1 during inflammation

Immune cells prevent bacteria, parasites or viruses from entering the body when, for example, the intestinal epithelium is injured.

26 Jul 2019

Hepatitis C News and Research

Latest Hepatitis C News and Research

Alarming number of life-threatening heart infections related to drug abuse

HCV-infected donor kidneys are safe and functional one year post-transplantation

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

Paid family leave increases immunization rates in infants

Facebook takes a stand against Anti-vaxxers and vaccine misinformation

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

Study finds transplantation of Hepatitis C-infected donor kidneys to uninfected recipients to be safe

NIH announces new round of funding for Research Centers in Minority Institutions

French organ transplant centers more likely to accept kidneys discarded in the United States

Needle stick injuries are common and can transmit many blood-borne pathogens

Enzyme induced by stress associated with liver cancer growth

Human apolipoprotein E promotes hepatitis B virus infection

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

Researchers awarded $1.8 million NIH grant to study chronic liver inflammation

HistoIndex, ILBS launch Center of Excellence to enhance NASH diagnostics and clinical trials

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

Trump administration ‘open for business’ on drug imports from Canada

UM researchers receive $14 million from NIH for cutting-edge HIV research

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

Researchers demonstrate positive and negative role of LRH-1 during inflammation

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in